Publications

https://www.ncbi.nlm.nih.gov/pubmed/?term=Panizzutti+R

Shawn Green, C., Bavelier, D., Kramer, A.F. et al. Improving Methodological Standards in Behavioral Interventions for Cognitive Enhancement J Cogn Enhanc (2019). https://doi.org/10.1007/s41465-018-0115-y

Madeira C, Alheira FV, Calcia MA, Silva TCS, Tannos FM, Vargas-Lopes C, Fisher M, Goldenstein N, Brasil MA, Vinogradov S, Ferreira ST, Panizzutti R. Blood Levels of Glutamate and Glutamine in Recent Onset and Chronic Schizophrenia. Front Psychiatry. 2018 19;9:713.

Panizzutti R, Fisher M, Garrett C, Man WH, Sena W, Madeira C, et al. Association between increased serum d -serine and cognitive gains induced by intensive cognitive training in schizophrenia. Schizophrenia Research. 2018 S0920-9964 (18) 30200-7.

Guercio GD, Panizzutti R. Potential and Challenges for the Clinical Use of d-Serine As a Cognitive Enhancer. Frontiers in Psychiatry. 2018 9:14. 

Madeira C, Vargas-Lopes C, Brandão CO, Reis T, Laks J, Panizzutti R, et al. Elevated Glutamate and Glutamine Levels in the Cerebrospinal Fluid of Patients With Probable Alzheimer’s Disease and Depression. Frontiers in Psychiatry. 2018 9:561.